1. American Psychiatric Association. (1994). DSM-IV: Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
2. American Psychiatric Association. (2012). DSM-V: The future of psychiatric diagnosis. Available at:
http://www.dsm5.org/Pages/Default.aspx
. Accessed April 2012.
3. Ashcroft, R., & Franey, C. (2004). Further ethical and social issues in using a cocaine vaccine: Response to Hall and Carter. Journal of Medical Ethics, 30(4), 341–343.
4. Ashcroft, R., Campbell, A., & Capps, B. (2007). Ethical aspects of developments in neuroscience and drug addiction. In D. Nutt, T. Robbins, G. Stimson, M. Ince, & A. Jackson (Eds.), Drugs and the future: Brain science addiction and society (pp. 439–465). London: Elsevier.
5. Australian National Council on Drugs (ANCD). (2012). Position statement: Naltrexone sustained release preparations (injectible & implants).
http://www.ancd.org.au/images/PDF/Positionstatements/naltrexonepositionstatement.pdf
. Accessed April 2012.